Understanding how HCV NS5A inhibitors work
Mechanistic function of HCV NS5A targeted by the potent inhibitors
This study is looking into how certain medications that help treat hepatitis C work at a tiny level, focusing on how they stop the virus from making copies of itself, which could lead to better treatments for people with hepatitis C.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10767288 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which NS5A inhibitors, crucial for treating hepatitis C virus (HCV), function at a molecular level. The team will explore how these inhibitors block specific structures formed by the NS5A protein, which are essential for HCV replication. Using advanced imaging techniques and in vitro models, the study aims to clarify the role of NS5A in membrane remodeling and how cholesterol influences this process. By uncovering these mechanisms, the research seeks to enhance the effectiveness of HCV therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hepatitis C who are seeking effective treatment options.
Not a fit: Patients with hepatitis C who are already cured or those with other unrelated liver conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved antiviral treatments for hepatitis C, potentially increasing cure rates and reducing the burden of the disease.
How similar studies have performed: Previous research has shown promising results with similar approaches in understanding viral mechanisms, indicating potential for success in this area.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Yi, Minkyung — University of Texas Med Br Galveston
- Study coordinator: Yi, Minkyung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.